JAZZ vs SNDL · P/E 1988, rev $2.28B vs $357.7M cap
Jazz Pharmaceuticals PLC (JAZZ) versus SNDL Inc. (SNDL) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
SNDL Inc. (SNDL) is a beverages - wineries & distilleries company listed on US.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
SNDL does not have a complete income-statement cache yet.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. SNDL currently screens at market cap $357.7M.
Not investment advice. Open the JAZZ and SNDL stock pages for the full models.
Not investment advice.